In Asian population of a systemic meta‐analysis, NRAS mutation melanoma had shorter mPFS (3.6 vs. 4.3 months, p = 0.015) and mOS (10.8 vs. 15.3 months, p = 0.025) than NRAS wild‐type melanoma [418]. The gene discussed is NRAS; the disease is melanoma.